Recent headlines from the sources AlphaScala monitors. AlphaScala analysis is published in the main market section.
India’s April CPI hit 3.5%, a 13-month high, as food inflation reached 4.2%. Rising costs and a weak rupee put rate hikes on RBI’s table ahead of monsoon risks.
The -4.3% quarterly swing in home loans casts doubt on the RBA's ability to hold rates, adding domestic pressure to an already strong US dollar.
Asian currencies slid against the dollar Wednesday after a hot US inflation print and a stalled Iran ceasefire reset the macro outlook. The next test is whether the Fed's hawkish repricing extends.
Oklo’s Q1 call transcript omits revenue and earnings. The participant list, Goldman, Cantor, B. Riley among others, maps the institutional desks pricing the name as an option on NRC approval.
The Canadian dollar held near 1.3700 after a hot US CPI print boosted the dollar, while crude rallied on Iran tensions. US retail sales data now looms.
Management expects Q3 and Q4 each above $10M. The J&J catheter transition adds execution risk, and Q2 shipment data will test the ramp.
The Q1 2026 earnings call transcript forces a check on SenesTech's shift from niche rodenticide to broad pest management. The next move hinges on reorder rates and pipeline conversion.
New spending capped at NZ$2.1 bln, NZ$300 mln below December plan, signals fiscal restraint that could narrow NZ-US yield spreads. The next budget update will test whether the government can stick to its surplus target amid global uncertainty.
Western Midstream's $683 million adjusted EBITDA included a skim oil windfall from the Aris acquisition, adding a crude-linked kicker to fee-based cash flows. The integration is complete, and throughput grew across all three product lines.
Always-on markets and constant alerts pressure traders into impulsive entries. The discipline of doing nothing is resurfacing as a capital-preservation tool.
HMS Bergbau AG acquired 43.3M Belmont shares, lifting its stake to 50.9% for $1.74M. Prices ranged $0.0333–$0.045/share. A German commodity marketer now controls the microcap miner, raising questions on board composition and offtake.
$TELA’s Europe revenue climbed 41%, and the OviTex LTR rollout provides a $20M Q2 guide that becomes the next concrete catalyst for the 8%+ full-year growth target.
The president's statement removes a near-term off-ramp for the conflict, keeping upward pressure on energy costs and defense spending. Traders must now price a longer war.
A Democratic senator signaled the party won't block a crypto market-structure bill, removing a major political obstacle. The risk now is whether bipartisan rhetoric translates into enforceable rules that unlock tokenized funds and onchain credit.
Large wallets are accumulating Zcash, Horizen, Bittensor, Render, and NEAR, signaling a structural bet on privacy and AI crypto infrastructure.
Trump's prioritization of trade over Iran at the Xi summit reduces dollar safe-haven demand, setting up potential rallies in AUD, NZD, and CNH.
Gold’s rally raises the stakes for Franco-Nevada’s royalty model. The May 12 annual meeting puts production visibility and capital allocation in the spotlight ahead of the Q2 update.
The White House confirms a Temple of Heaven visit during the Beijing summit. The symbolic gesture may reset trade expectations for tech and agriculture.
First-quarter revenue hit $19.8 million and adjusted EBITDA reached $3.3 million, each above the Street view. The release provided no full-year outlook or segment split, making the Q&A session the next real catalyst.
Management cited double-digit Q1 growth across TAVR, surgical, mitral, and tricuspid segments, signaling that the entire structural heart market is expanding. The next test is the Q2 earnings report.
Binance handles 40% of global spot crypto volume vs Coinbase's 6% as U.S. regulatory vacuum pushes $2.4T in flows offshore. 55M American crypto holders await Senate vote.
The raised 2026 guide and 4-7 year written contingent demand commitments change the pitch for Karman: a backlog conversion story with a $1B+ cushion.
CEO Thomas Berge framed the European CPaaS leader with 66,000 customers and roughly 700 employees. The Q1 print must now show that post-merger scale translates into EBITDA growth.
Hotter-than-expected April inflation and renewed Iran strike risk hit Asian equities, with South Korea's Kospi falling 2.15%. Next catalyst: Trump-Xi meeting trade talks.
The partnership combines Kraken’s crypto-native distribution and custody with Franklin Templeton’s regulated fund complex, setting up a potential gateway for on-chain stock trading. Next catalyst: a regulatory filing that defines the wrapper.
GRAIL CFO Aaron Freidin says private-pay digital health channels are performing well, reducing dependence on the NHS Galleri trial. Next catalyst: quarterly channel growth data.
CFO Joel Ackerman addressed Q1 treatment volumes at the BofA conference, keeping the focus on the metric that drives dialysis stocks. The next tradeable signal arrives with Q2 earnings and the CMS rate update.
Japan's BOP trade surplus swelled to ¥3900B in March from ¥2709B, reinforcing the yen's current-account support and raising the bar for a sustained USD/JPY upside break.
ZachXBT traced 185 BTC (~$19M) to a wallet linked to Dritan Kapllani Jr. A complaint against accomplice Trenton Johnson revealed an Exodus wallet connection.
CRISPR Therapeutics expects data from six pipeline programs within 12–18 months, starting with cardiovascular disease. The readouts shift focus from CASGEVY's launch to platform validation.